Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).
An open-label trial of escitalopram in pervasive developmental disorders.
Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.
Principal Investigator
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
An open-label trial of escitalopram in pervasive developmental disorders.
An open-label trial of escitalopram in pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 2005 Apr; 44(4):343-8.
View in:
PubMed
subject areas
Adolescent
Autistic Disorder
Child
Child Development Disorders, Pervasive
Citalopram
Dose-Response Relationship, Drug
Female
Humans
Male
Prospective Studies
authors with profiles
Bennett Leventhal